HSBC has maintained its ‘buy’ rating on SBI Life Insurance, raising the target price to ₹1,800 from ₹1,720. The brokerage expects annual premium equivalent (APE) growth to improve in the coming quarters, supporting the company’s growth trajectory.
HSBC highlights that SBI Life’s valuation appears supportive and presents a strong case for compounding returns. Furthermore, the valuation has the potential to re-rate as the growth trajectory strengthens.
At the current market price (CMP) of ₹1,539.05, HSBC’s target price implies a 17% upside, underscoring SBI Life’s robust fundamentals and long-term prospects.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers are advised to consult with their financial advisor before making any investment decisions.